Shubham Maheshwari, the Chief Financial Officer of Varex Imaging Corp (NASDAQ:VREX), has recently made a significant purchase of the company's stock. On August 9, Maheshwari acquired 9,007 shares at a weighted average price ranging from $10.95 to $11.00 per share, with the total transaction amounting to approximately $98,896.
The purchase demonstrates a strong vote of confidence from the CFO in the company's future prospects. Following this transaction, Maheshwari now beneficially owns a total of 46,063 shares of Varex Imaging Corp. This includes 1,276 shares purchased under the Varex Imaging Corporation 2017 Employee Stock Purchase Plan, as noted in the footnotes of the filing.
Investors often monitor insider buying as it can signal executives' belief in the company's value and growth potential. Maheshwari's acquisition at an average price of $10.98 per share represents a notable investment in the company by a key insider.
Varex Imaging Corp, based in Salt Lake City, Utah, specializes in manufacturing electronic components and is known for its role in the medical imaging industry. The company's stock is publicly traded on NASDAQ under the ticker symbol VREX.
The recent filing with the Securities and Exchange Commission provides transparency into the actions of Varex's insiders, offering investors a glimpse into the confidence level of the company's management.
In other recent news, Varex Imaging Corporation reported mixed results for its third quarter of fiscal year 2024. The company experienced a 10% decline in revenue compared to the same period last year, with a significant 15% decrease in the Medical segment, while the Industrial segment saw a 6% increase in revenue. Despite these challenges, Varex maintained a strong cash position of $192 million.
The company's future plans include measures to navigate through the current challenges and capitalize on growth opportunities. As part of this strategy, Varex is looking into cost-cutting initiatives and investments in India to regain market share in radiographic and dental areas.
However, Varex is facing challenges in the Chinese market and increased competition from Asia-based manufacturers. The company's management has expressed optimism for the industrial segment and new technology developments, despite these challenges. These recent developments highlight the evolving dynamics of Varex's financial performance and strategic direction.
InvestingPro Insights
Following the recent insider stock purchase by Varex Imaging Corp's CFO, Shubham Maheshwari, the market has seen varied activity in the company's shares. According to real-time data from InvestingPro, Varex Imaging Corp (NASDAQ:VREX) has a market capitalization of approximately $439.26 million, with a P/E ratio standing at 12.87. This valuation is underpinned by a revenue of $832.7 million over the last twelve months as of Q3 2024, although this represents a decrease of 7.21% in revenue growth during the same period.
InvestingPro Tips suggest caution, as the stock is currently in oversold territory, which might indicate a potential rebound or further declines depending on broader market trends and company-specific developments. The tips also highlight that two analysts have revised their earnings expectations downwards for the upcoming period, which may warrant investor attention. Despite these challenges, Varex's valuation implies a strong free cash flow yield, which could be a silver lining for value-oriented investors.
For those considering following the CFO's lead, it's worth noting that Varex is trading near its 52-week low, which might suggest a buying opportunity if one believes in the company's fundamentals and long-term potential. For further insights, InvestingPro offers additional tips on Varex Imaging Corp, which can be explored to inform investment decisions.
It's important for investors to consider these metrics and tips in the context of their investment strategy and the broader market environment. With a total of 12 tips available on InvestingPro for Varex Imaging Corp, investors can delve deeper into the company's performance and potential before making any decisions.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.